• Exchange: NASDAQ CM
  • Sector: Technology
  • Industry: Software
  • Sub-Industry: Application Software

Simulations Plus Inc

+ Add to Watchlist


7.0000 USD 0.00000.00%

As of 20:10:00 ET on 09/19/2014.

Snapshot for Simulations Plus Inc (SLP)

Open: 7.0000 Day's Range: 6.9645 - 7.0500 Volume: 137,298
Previous Close: 7.0000 52wk Range: 4.6701 - 7.0900 1-Yr Rtn: +51.28%

Stock Chart for SLP

No chart data available.
  • SLP:US 7.0000
  • 1D
  • 1M
  • 1Y
Interactive SLP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SLP

Current P/E Ratio (ttm) 36.8421
Estimated P/E(08/2014) 36.8421
Relative P/E vs. SPX 2.0266
Earnings Per Share (USD) (ttm) 0.1900
Est. EPS (USD) (08/2014) 0.1900
Est. PEG Ratio 1.8421
Market Cap (M USD) 114.40
Shares Outstanding (M) 16.34
30 Day Average Volume 25,918
Price/Book (mrq) 7.1624
Price/Sale (ttm) 10.2241
Dividend Indicated Gross Yield 2.86%
Cash Dividend (USD) 0.0500
Dividend Ex-Date 07/31/2014
5 Year Dividend Growth -
Next Earnings Announcement 11/19/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SLP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SLP

Simulations Plus, Inc. develops drug discovery and development simulation software, which is licensed to and used in the conduct of drug research for pharmaceutical companies worldwide. The Company's other businesses are based on its proprietary software technologies and provide support for the emerging pharmaceutical enterprise.

Walter S Woltosz "Walt"Chairman/CEO/Co-FounderThaddeus H Grasela "Ted"President
John R KneiselChief Financial OfficerMichael BolgerChief Scientist
More Company Profile & Key Executives for SLP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil